You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 163 No. 2, January 27, 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (47)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in this journal
 Topic Collections
 •Osteoarthritis
 •Randomized Controlled Trial
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Lack of Efficacy of Acetaminophen in Treating Symptomatic Knee Osteoarthritis

A Randomized, Double-blind, Placebo-Controlled Comparison Trial With Diclofenac Sodium

John P. Case, MD; Algis J. Baliunas; Joel A. Block, MD

Arch Intern Med. 2003;163:169-178.

Background  Recommendations state that acetaminophen should be used in preference to nonsteroidal anti-inflammatory drugs in the initial treatment of symptomatic osteoarthritis (OA) of the hip or knee, because of lesser toxicity and the pervasive belief that acetaminophen is not only effective in treating OA pain but is of equal analgesic efficacy as nonsteroidal anti-inflammatory drugs.

Methods  This was a randomized, double-blind, placebo-controlled trial of diclofenac sodium, 75 mg twice daily, vs acetaminophen, 1000 mg 4 times daily, in 82 subjects with symptomatic OA of the medial knee. Osteoarthritis was quantitated radiographically, and subjects met stringent baseline pain criteria. The primary evaluation of efficacy used the Western Ontario and McMaster Universities Osteoarthritis Index, with evaluations at screening, baseline, and 2 and 12 weeks after treatment. Intention-to-treat analysis was used.

Results  Twenty-five subjects were randomized to diclofenac, 29 to acetaminophen, and 28 to placebo. The groups were closely matched for age, sex, body mass index, prior use of OA medications, baseline pain, and radiographic features. At 2 and 12 weeks, clinically and statistically significant (P<.001) improvements were seen in the diclofenac-treated group; however, no significant improvements were seen in the acetaminophen-treated group (P = .92 at 2 weeks and .19 at 12 weeks). Stratification of subjects according to baseline pain, prestudy OA medication, and radiographic grade showed no clear pattern of preferential response to diclofenac, and did not reveal a subset of subjects who responded to acetaminophen.

Conclusions  Diclofenac is effective in the symptomatic treatment of OA of the knee, but acetaminophen is not. A review of the literature reveals that there is scanty published evidence for a therapeutic effect of acetaminophen relative to placebo in patients with OA of the knee, because most published studies use active comparators (ie, nonsteroidal anti-inflammatory drugs) only. The advocacy of acetaminophen use in subjects with OA of the knee should be reconsidered pending further placebo-controlled studies.


From the Section of Rheumatology, Rush Medical College, Rush University (Drs Case and Block), the Division of Rheumatology, Cook County Hospital (Dr Case), and Rush Medical College, Rush University (Mr Baliunas), Chicago, Ill.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Interpretation of Therapies for Knee Arthritis
Colleen Christmas and Lainie Moncada
Arch Intern Med. 2003;163(15):1862.
EXTRACT | FULL TEXT  

What Now About Acetaminophen?
Marcel Zwahlen, Peter Jüni, and Matthias Egger
Arch Intern Med. 2003;163(15):1862-1863.
EXTRACT | FULL TEXT  

What Now About Acetaminophen?—Reply
John P. Case, Algis Baliunas, and Joel A. Block
Arch Intern Med. 2003;163(15):1863.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Osteoarthritis: An Update on Data Currently Reshaping Practice
Epstein and Taylor
Journal of Pharmacy Practice 2009;22:75-85.
ABSTRACT  

Osteoarthritis of the Hip
Lane
NEJM 2007;357:1413-1421.
FULL TEXT  

Osteoarthritis, angiogenesis and inflammation
Bonnet and Walsh
Rheumatology (Oxford) 2005;44:7-16.
ABSTRACT | FULL TEXT  

Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials
Bjordal et al.
BMJ 2004;329:1317.
ABSTRACT | FULL TEXT  

A historic issue of the Annals: three papers examine paracetamol in osteoarthritis
Neame et al.
Ann Rheum Dis 2004;63:897-900.
FULL TEXT  

Does paracetamol (acetaminophen) reduce the pain of osteoarthritis?: a meta-analysis of randomised controlled trials
Zhang et al.
Ann Rheum Dis 2004;63:901-907.
ABSTRACT | FULL TEXT  

Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis
Pincus et al.
Ann Rheum Dis 2004;63:931-939.
ABSTRACT | FULL TEXT  

Pharmacologic Management of Foot Pain in the Older Patient
Martin
J. Am. Podiatr. Med. Assoc. 2004;94:98-103.
ABSTRACT | FULL TEXT  

Interpretation of Therapies for Knee Arthritis
Christmas and Moncada
Arch Intern Med 2003;163:1862-1862.
FULL TEXT  

What Now About Acetaminophen?
Zwahlen et al.
Arch Intern Med 2003;163:1862-1863.
FULL TEXT  

Treating Knee Osteoarthritis: Acetaminophen Is Not Effective, but Diclofenac Is
JWatch Emergency Med. 2003;2003:3-3.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.